Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovat
About this program
The Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) grant is designed to support clinical trials that are initiated by investigators at a single site. This funding opportunity is aimed at researchers who have innovative ideas for clinical trials that can lead to significant advancements in medical science. The grant provides the necessary resources to conduct these trials, ensuring that researchers can test their hypotheses and gather valuable data. Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in clinical research. The grant is structured to support both the planning and execution phases of the trial, allowing for a comprehensive approach to clinical investigation. By providing funding for both the R61 and R33 phases, the grant facilitates a smooth transition from preliminary research to full-scale clinical trials, ultimately contributing to the advancement of healthcare solutions.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in clinical research.